Welcome to LookChem.com Sign In|Join Free

CAS

  • or

827026-45-9

Post Buying Request

827026-45-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

827026-45-9 Usage

Chemical Properties

White crystalline

Uses

Different sources of media describe the Uses of 827026-45-9 differently. You can refer to the following data:
1. Lenalidomide (L328000) analog. Lenalidomide impurity; Lenalidomide intermediate.
2. Lenalidomide (L328000) analog. Lenalidomide impurity.

Check Digit Verification of cas no

The CAS Registry Mumber 827026-45-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,2,7,0,2 and 6 respectively; the second part has 2 digits, 4 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 827026-45:
(8*8)+(7*2)+(6*7)+(5*0)+(4*2)+(3*6)+(2*4)+(1*5)=159
159 % 10 = 9
So 827026-45-9 is a valid CAS Registry Number.
InChI:InChI=1/C13H11N3O5/c17-11-5-4-10(12(18)14-11)15-6-8-7(13(15)19)2-1-3-9(8)16(20)21/h1-3,10H,4-6H2,(H,14,17,18)

827026-45-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name (3S)-3-(4-Nitro-1-oxo-1,3-dihydro-2H-isoindol-2-yl)piperidine-2,6-dione

1.2 Other means of identification

Product number -
Other names 3-(7-nitro-3-oxo-1H-isoindol-2-yl)piperidine-2,6-dione

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:827026-45-9 SDS

827026-45-9Synthetic route

rac-α-aminoglutarimide hydrochloride
24666-56-6

rac-α-aminoglutarimide hydrochloride

2-bromomethyl-3-nitro-benzoic acid methyl ester
98475-07-1

2-bromomethyl-3-nitro-benzoic acid methyl ester

3-(4-nitro-1-oxoisoindolin-2-yl)piperidine-2,6-dione
827026-45-9

3-(4-nitro-1-oxoisoindolin-2-yl)piperidine-2,6-dione

Conditions
ConditionsYield
Stage #1: rac-α-aminoglutarimide hydrochloride With triethylamine In dimethyl sulfoxide for 0.166667h; Inert atmosphere;
Stage #2: 2-bromomethyl-3-nitro-benzoic acid methyl ester In dimethyl sulfoxide at 50 - 55℃; for 12.3333h; Inert atmosphere;
99.73%
With sodium carbonate at 100℃; for 0.75h; Reagent/catalyst; Temperature; Inert atmosphere;98.5%
With sodium carbonate In acetonitrile at 70℃; for 8h; Solvent; Reagent/catalyst; Temperature;98.8%
2-bromomethyl-3-nitro-benzoic acid methyl ester
98475-07-1

2-bromomethyl-3-nitro-benzoic acid methyl ester

(+/-)-α-aminoglutarimide
2353-44-8

(+/-)-α-aminoglutarimide

3-(4-nitro-1-oxoisoindolin-2-yl)piperidine-2,6-dione
827026-45-9

3-(4-nitro-1-oxoisoindolin-2-yl)piperidine-2,6-dione

Conditions
ConditionsYield
In N,N-dimethyl-formamide for 3h; Reflux;96%
Stage #1: 2-bromomethyl-3-nitro-benzoic acid methyl ester; (+/-)-α-aminoglutarimide With sodium carbonate In acetonitrile at 5℃; Inert atmosphere; Reflux; Large scale;
Stage #2: With hydrogenchloride In water at 20 - 62℃; for 4h; pH=< 6; Large scale;
79.5%
With triethylamine In N,N-dimethyl-formamide at 25 - 100℃; for 7h; Inert atmosphere;
With potassium hydrogencarbonate In acetonitrile Reflux;
With triethylamine In N,N-dimethyl-formamide at 75℃; for 20h;
3-(4-nitro-1,3-dihydro-2H-isoindol-2-yl)piperidine-2,6-dione

3-(4-nitro-1,3-dihydro-2H-isoindol-2-yl)piperidine-2,6-dione

3-(4-nitro-1-oxoisoindolin-2-yl)piperidine-2,6-dione
827026-45-9

3-(4-nitro-1-oxoisoindolin-2-yl)piperidine-2,6-dione

Conditions
ConditionsYield
With 5-trimethylammonio-1,3-dioxo-1,3-dihydro-1λ5-benzo[d][1,2]-iodoxol-1-ol anion In water at 50 - 70℃;94.1%
With tert.-butylhydroperoxide; copper(ll) sulfate pentahydrate; oxygen In 1,4-dioxane at 70℃; for 3h; Temperature; Reagent/catalyst; Solvent;78%
methyl 2-(chloromethyl)-3-nitrobenzoate

methyl 2-(chloromethyl)-3-nitrobenzoate

rac-α-aminoglutarimide hydrochloride
24666-56-6

rac-α-aminoglutarimide hydrochloride

3-(4-nitro-1-oxoisoindolin-2-yl)piperidine-2,6-dione
827026-45-9

3-(4-nitro-1-oxoisoindolin-2-yl)piperidine-2,6-dione

Conditions
ConditionsYield
With triethylamine In acetonitrile at 80℃; for 10h;93.2%
2-methyl-3-nitro-benzoic acid methyl ester
59382-59-1

2-methyl-3-nitro-benzoic acid methyl ester

(+/-)-α-aminoglutarimide
2353-44-8

(+/-)-α-aminoglutarimide

3-(4-nitro-1-oxoisoindolin-2-yl)piperidine-2,6-dione
827026-45-9

3-(4-nitro-1-oxoisoindolin-2-yl)piperidine-2,6-dione

Conditions
ConditionsYield
With N,N,N,N,-tetramethylethylenediamine; zinc dibromide In 1,4-dioxane at 95℃; Temperature;90.7%
2-amino-3-tert-butoxypropionic acid
17083-25-9

2-amino-3-tert-butoxypropionic acid

2-bromomethyl-3-nitro-benzoic acid methyl ester
98475-07-1

2-bromomethyl-3-nitro-benzoic acid methyl ester

3-(4-nitro-1-oxoisoindolin-2-yl)piperidine-2,6-dione
827026-45-9

3-(4-nitro-1-oxoisoindolin-2-yl)piperidine-2,6-dione

Conditions
ConditionsYield
Stage #1: 2-amino-3-tert-butoxypropionic acid; 2-bromomethyl-3-nitro-benzoic acid methyl ester With sodium hydrogencarbonate In acetonitrile at 5 - 20℃; Reflux;
Stage #2: With hydrogenchloride In water at 58 - 62℃; for 4.16667h; pH=< 6; Temperature; Time;
79.5%
4-carbamoyl-4-(4-nitro-1-oxo-1,3-dihydroisoindol-2-yl)butyric acid
1198299-72-7

4-carbamoyl-4-(4-nitro-1-oxo-1,3-dihydroisoindol-2-yl)butyric acid

3-(4-nitro-1-oxoisoindolin-2-yl)piperidine-2,6-dione
827026-45-9

3-(4-nitro-1-oxoisoindolin-2-yl)piperidine-2,6-dione

Conditions
ConditionsYield
With thionyl chloride In N,N-dimethyl-formamide at 0℃;78%
methyl 2-(chloromethyl)-3-nitrobenzoate

methyl 2-(chloromethyl)-3-nitrobenzoate

(+/-)-α-aminoglutarimide
2353-44-8

(+/-)-α-aminoglutarimide

3-(4-nitro-1-oxoisoindolin-2-yl)piperidine-2,6-dione
827026-45-9

3-(4-nitro-1-oxoisoindolin-2-yl)piperidine-2,6-dione

Conditions
ConditionsYield
With ammonium hydroxide In N,N-dimethyl-formamide for 2h; Reflux;75%
2-bromomethyl-3-nitro-benzoic acid methyl ester
98475-07-1

2-bromomethyl-3-nitro-benzoic acid methyl ester

(RS)-2,6-dioxopiperidin-3-yl-ammonium trifluoroacetate

(RS)-2,6-dioxopiperidin-3-yl-ammonium trifluoroacetate

3-(4-nitro-1-oxoisoindolin-2-yl)piperidine-2,6-dione
827026-45-9

3-(4-nitro-1-oxoisoindolin-2-yl)piperidine-2,6-dione

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl acetamide at 20 - 50℃; for 40.5h; Inert atmosphere;73%
3-aminopiperidine-2,6-dione hydrobromide
90802-45-2

3-aminopiperidine-2,6-dione hydrobromide

2-bromomethyl-3-nitro-benzoic acid methyl ester
98475-07-1

2-bromomethyl-3-nitro-benzoic acid methyl ester

3-(4-nitro-1-oxoisoindolin-2-yl)piperidine-2,6-dione
827026-45-9

3-(4-nitro-1-oxoisoindolin-2-yl)piperidine-2,6-dione

Conditions
ConditionsYield
With triethylamine In acetonitrile at 20 - 80℃; for 10h;65.2%
3-aminopiperidine-2,6-dione hydrochloric acid salt

3-aminopiperidine-2,6-dione hydrochloric acid salt

2-bromomethyl-3-nitro-benzoic acid methyl ester
98475-07-1

2-bromomethyl-3-nitro-benzoic acid methyl ester

3-(4-nitro-1-oxoisoindolin-2-yl)piperidine-2,6-dione
827026-45-9

3-(4-nitro-1-oxoisoindolin-2-yl)piperidine-2,6-dione

Conditions
ConditionsYield
With triethylamine In N,N-dimethyl acetamide at 85℃; for 4h;56%
2-methyl-3-nitro-benzoic acid methyl ester
59382-59-1

2-methyl-3-nitro-benzoic acid methyl ester

3-(4-nitro-1-oxoisoindolin-2-yl)piperidine-2,6-dione
827026-45-9

3-(4-nitro-1-oxoisoindolin-2-yl)piperidine-2,6-dione

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: NBS / CCl4 / Heating; Irradiation
2: Et3N / dimethylformamide / 80 °C
View Scheme
Multi-step reaction with 2 steps
1.1: dibenzoyl peroxide; N-Bromosuccinimide / tetrachloromethane / 93 h / Reflux
2.1: acetonitrile / 0.25 h / 20 °C
2.2: 7 h / 20 °C / Reflux
View Scheme
Multi-step reaction with 2 steps
1: N-Bromosuccinimide / 2,2'-azobis(isobutyronitrile) / chlorobenzene / 6 h / 90 - 95 °C / Inert atmosphere
2: triethylamine / N,N-dimethyl-formamide / 7 h / 25 - 100 °C / Inert atmosphere
View Scheme
Cbz-L-Gln
2650-64-8

Cbz-L-Gln

3-(4-nitro-1-oxoisoindolin-2-yl)piperidine-2,6-dione
827026-45-9

3-(4-nitro-1-oxoisoindolin-2-yl)piperidine-2,6-dione

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: CDI / tetrahydrofuran / Heating
2: H2, aq. HCl / 10 percent Pd/C / ethyl acetate / 2585.74 - 3102.89 Torr
3: Et3N / dimethylformamide / 80 °C
View Scheme
Multi-step reaction with 2 steps
1.1: 1,1'-carbonyldiimidazole / tetrahydrofuran / 2.5 h / 25 - 70 °C
2.1: palladium 10% on activated carbon; hydrogen / methanol / 2 h / 25 - 35 °C
2.2: 6 h / 25 - 35 °C
View Scheme
Multi-step reaction with 3 steps
1: dmap; 1,1'-carbonyldiimidazole / 1,4-dioxane / 15 h / 100 °C
2: hydrogen bromide; acetic acid / 1 h / 60 °C
3: triethylamine / acetonitrile / 10 h / 20 - 80 °C
View Scheme
3-(benzyloxycarbonyl)-amino-2,6-dioxopiperidine
24666-55-5

3-(benzyloxycarbonyl)-amino-2,6-dioxopiperidine

3-(4-nitro-1-oxoisoindolin-2-yl)piperidine-2,6-dione
827026-45-9

3-(4-nitro-1-oxoisoindolin-2-yl)piperidine-2,6-dione

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: H2, aq. HCl / 10 percent Pd/C / ethyl acetate / 2585.74 - 3102.89 Torr
2: Et3N / dimethylformamide / 80 °C
View Scheme
Multi-step reaction with 2 steps
1: hydrogen bromide; acetic acid / 1 h / 60 °C
2: triethylamine / acetonitrile / 10 h / 20 - 80 °C
View Scheme
2-(4-nitro-1-oxo-1,3-dihydro-isoindol-2-yl)-pentanedioic acid diamide

2-(4-nitro-1-oxo-1,3-dihydro-isoindol-2-yl)-pentanedioic acid diamide

3-(4-nitro-1-oxoisoindolin-2-yl)piperidine-2,6-dione
827026-45-9

3-(4-nitro-1-oxoisoindolin-2-yl)piperidine-2,6-dione

Conditions
ConditionsYield
With formamide at 160 - 170℃; Product distribution / selectivity;
2-(4-nitro-1-oxo-1,3-dihydroisoindol-2-yl)glutaric acid dimethyl ester
827026-43-7

2-(4-nitro-1-oxo-1,3-dihydroisoindol-2-yl)glutaric acid dimethyl ester

3-(4-nitro-1-oxoisoindolin-2-yl)piperidine-2,6-dione
827026-45-9

3-(4-nitro-1-oxoisoindolin-2-yl)piperidine-2,6-dione

Conditions
ConditionsYield
With formamide at 160 - 170℃; Product distribution / selectivity;
With sodium amide In tetrahydrofuran; water at 20℃; Product distribution / selectivity;
N-benzyloxycarbonyl-L-isoglutamine
6398-06-7

N-benzyloxycarbonyl-L-isoglutamine

3-(4-nitro-1-oxoisoindolin-2-yl)piperidine-2,6-dione
827026-45-9

3-(4-nitro-1-oxoisoindolin-2-yl)piperidine-2,6-dione

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1.1: dmap; 1,1'-carbonyldiimidazole / tetrahydrofuran / 20 h / Reflux
2.1: hydrogenchloride; hydrogen / palladium 10% on activated carbon / methanol / 23 h / 760.05 Torr
3.1: acetonitrile / 0.25 h / 20 °C
3.2: 7 h / 20 °C / Reflux
View Scheme
N-(2,6-dioxopiperidin-3-yl)-2-phenylacetamide

N-(2,6-dioxopiperidin-3-yl)-2-phenylacetamide

3-(4-nitro-1-oxoisoindolin-2-yl)piperidine-2,6-dione
827026-45-9

3-(4-nitro-1-oxoisoindolin-2-yl)piperidine-2,6-dione

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: hydrogenchloride; hydrogen / palladium 10% on activated carbon / methanol / 23 h / 760.05 Torr
2.1: acetonitrile / 0.25 h / 20 °C
2.2: 7 h / 20 °C / Reflux
View Scheme
2-bromomethyl-3-nitro-benzoic acid methyl ester
98475-07-1

2-bromomethyl-3-nitro-benzoic acid methyl ester

3-(benzyloxycarbonyl)-amino-2,6-dioxopiperidine
24666-55-5

3-(benzyloxycarbonyl)-amino-2,6-dioxopiperidine

3-(4-nitro-1-oxoisoindolin-2-yl)piperidine-2,6-dione
827026-45-9

3-(4-nitro-1-oxoisoindolin-2-yl)piperidine-2,6-dione

Conditions
ConditionsYield
Stage #1: 3-(benzyloxycarbonyl)-amino-2,6-dioxopiperidine With palladium 10% on activated carbon; hydrogen In methanol at 25 - 35℃; for 2h;
Stage #2: 2-bromomethyl-3-nitro-benzoic acid methyl ester With triethylamine In N,N-dimethyl-formamide at 25 - 35℃; for 6h;
77 g
(S)-methyl 5-amino-2-(tert-butoxycarbonylamino)-5-oxopentanoate
4976-88-9

(S)-methyl 5-amino-2-(tert-butoxycarbonylamino)-5-oxopentanoate

3-(4-nitro-1-oxoisoindolin-2-yl)piperidine-2,6-dione
827026-45-9

3-(4-nitro-1-oxoisoindolin-2-yl)piperidine-2,6-dione

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 1,1'-carbonyldiimidazole; dmap / tetrahydrofuran / 48 h / Reflux
2: water; sodium chloride / 4 h / Reflux
3: N,N-dimethyl-formamide / 3 h / Reflux
View Scheme
(RS)-(2,6-dioxopiperidin-3-yl)carbamic acid tert-butyl ester
31140-42-8

(RS)-(2,6-dioxopiperidin-3-yl)carbamic acid tert-butyl ester

3-(4-nitro-1-oxoisoindolin-2-yl)piperidine-2,6-dione
827026-45-9

3-(4-nitro-1-oxoisoindolin-2-yl)piperidine-2,6-dione

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: water; sodium chloride / 4 h / Reflux
2: N,N-dimethyl-formamide / 3 h / Reflux
View Scheme
Multi-step reaction with 2 steps
1: trifluoroacetic acid / dichloromethane / 20 °C
2: potassium hydrogencarbonate / acetonitrile / Reflux
View Scheme
Multi-step reaction with 2 steps
1: hydrogenchloride / water; tert-butyl methyl ether / 0.33 h / 0 °C
2: ammonium hydroxide / N,N-dimethyl-formamide / 2 h / Reflux
View Scheme
Boc-Gln-OH
13726-85-7

Boc-Gln-OH

3-(4-nitro-1-oxoisoindolin-2-yl)piperidine-2,6-dione
827026-45-9

3-(4-nitro-1-oxoisoindolin-2-yl)piperidine-2,6-dione

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: dicyclohexyl-carbodiimide; dmap / acetonitrile / 20 °C
2: trifluoroacetic acid / dichloromethane / 20 °C
3: potassium hydrogencarbonate / acetonitrile / Reflux
View Scheme
2-methyl-3-nitrobenzic acid
1975-50-4

2-methyl-3-nitrobenzic acid

3-(4-nitro-1-oxoisoindolin-2-yl)piperidine-2,6-dione
827026-45-9

3-(4-nitro-1-oxoisoindolin-2-yl)piperidine-2,6-dione

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1.1: thionyl chloride / dichloromethane / Reflux
1.2: Reflux
2.1: bromine / tetrachloromethane / 20 °C
3.1: potassium hydrogencarbonate / acetonitrile / Reflux
View Scheme
Multi-step reaction with 3 steps
1: bis(trichloromethyl) carbonate / N,N-dimethyl-formamide / 6 h / Reflux
2: N-Bromosuccinimide; dibenzoyl peroxide / 8 h / Reflux
3: triethylamine / acetonitrile / 3 h / Reflux
View Scheme
Multi-step reaction with 3 steps
1.1: acetone / 0.17 h / 25 - 30 °C
1.2: 1.5 h / 25 - 30 °C
2.1: N-Bromosuccinimide; 2,2'-azobis(isobutyronitrile) / acetonitrile / 12 h / 55 - 60 °C
3.1: triethylamine / dimethyl sulfoxide / 0.17 h / Inert atmosphere
3.2: 12.33 h / 50 - 55 °C / Inert atmosphere
View Scheme
L-glutamic acid
56-86-0

L-glutamic acid

3-(4-nitro-1-oxoisoindolin-2-yl)piperidine-2,6-dione
827026-45-9

3-(4-nitro-1-oxoisoindolin-2-yl)piperidine-2,6-dione

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: water / 2 h / 0 °C
2: urea / dimethyl sulfoxide / 2 h / 150 °C
3: hydrogenchloride / dimethyl sulfoxide
4: triethylamine / acetonitrile / 3 h / Reflux
View Scheme
N-benzyloxycarbonyl-L-glutamic acid
1155-62-0

N-benzyloxycarbonyl-L-glutamic acid

3-(4-nitro-1-oxoisoindolin-2-yl)piperidine-2,6-dione
827026-45-9

3-(4-nitro-1-oxoisoindolin-2-yl)piperidine-2,6-dione

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: urea / dimethyl sulfoxide / 2 h / 150 °C
2: hydrogenchloride / dimethyl sulfoxide
3: triethylamine / acetonitrile / 3 h / Reflux
View Scheme
4-nitroisoindoline

4-nitroisoindoline

3-(4-nitro-1-oxoisoindolin-2-yl)piperidine-2,6-dione
827026-45-9

3-(4-nitro-1-oxoisoindolin-2-yl)piperidine-2,6-dione

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: copper(l) iodide; potassium carbonate / tetrahydrofuran / 6 h / 60 °C
2: 5-trimethylammonio-1,3-dioxo-1,3-dihydro-1λ5-benzo[d][1,2]-iodoxol-1-ol anion / water / 50 - 70 °C
View Scheme
3-(4-nitro-1,3-dihydro-2H-isoindol-2-yl)piperidine-2,6-dione

3-(4-nitro-1,3-dihydro-2H-isoindol-2-yl)piperidine-2,6-dione

A

4-NT
19171-18-7

4-NT

B

3-(4-nitro-1-oxoisoindolin-2-yl)piperidine-2,6-dione
827026-45-9

3-(4-nitro-1-oxoisoindolin-2-yl)piperidine-2,6-dione

C

3-(4-nitro-3-oxo-1,3-dihydroisoindol-2-yl)piperidine-2,6-dione
1063995-54-9

3-(4-nitro-3-oxo-1,3-dihydroisoindol-2-yl)piperidine-2,6-dione

Conditions
ConditionsYield
With potassium permanganate In water at 50 - 70℃;
isoindoline
496-12-8

isoindoline

A

4-NT
19171-18-7

4-NT

B

3-(4-nitro-1-oxoisoindolin-2-yl)piperidine-2,6-dione
827026-45-9

3-(4-nitro-1-oxoisoindolin-2-yl)piperidine-2,6-dione

C

3-(4-nitro-3-oxo-1,3-dihydroisoindol-2-yl)piperidine-2,6-dione
1063995-54-9

3-(4-nitro-3-oxo-1,3-dihydroisoindol-2-yl)piperidine-2,6-dione

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: nitric acid; sulfuric acid / 8.5 h / 20 °C / Cooling with ice
2: copper(l) iodide; potassium carbonate / tetrahydrofuran / 6 h / 60 °C
3: potassium permanganate / water / 50 - 70 °C
View Scheme
isoindoline
496-12-8

isoindoline

3-(4-nitro-1-oxoisoindolin-2-yl)piperidine-2,6-dione
827026-45-9

3-(4-nitro-1-oxoisoindolin-2-yl)piperidine-2,6-dione

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: nitric acid; sulfuric acid / 8.5 h / 20 °C / Cooling with ice
2: copper(l) iodide; potassium carbonate / tetrahydrofuran / 6 h / 60 °C
3: 5-trimethylammonio-1,3-dioxo-1,3-dihydro-1λ5-benzo[d][1,2]-iodoxol-1-ol anion / water / 50 - 70 °C
View Scheme
3-(4-nitro-1-oxoisoindolin-2-yl)piperidine-2,6-dione
827026-45-9

3-(4-nitro-1-oxoisoindolin-2-yl)piperidine-2,6-dione

Conditions
ConditionsYield
With 5%-palladium/activated carbon; hydrogen In ethanol at 40℃; under 3000.3 Torr; Pressure; Temperature;98.2%
With sodium sulfide; ethanol at 20℃; for 1h;98%
With sodium tetrahydroborate; ammonium chloride In ethanol; water at 90℃; for 1h; Reagent/catalyst;98%
3-(4-nitro-1-oxoisoindolin-2-yl)piperidine-2,6-dione
827026-45-9

3-(4-nitro-1-oxoisoindolin-2-yl)piperidine-2,6-dione

4-nitro-1-thioxo-2-(2-oxo-6-thioxopiperidine-3-yl)phthalimidine
1195729-61-3

4-nitro-1-thioxo-2-(2-oxo-6-thioxopiperidine-3-yl)phthalimidine

Conditions
ConditionsYield
With Lawessons reagent In toluene for 26h; Inert atmosphere; Reflux;85.8%
With Lawessons reagent In 1,4-dioxane for 5h; Reflux;64%
3-(4-nitro-1-oxoisoindolin-2-yl)piperidine-2,6-dione
827026-45-9

3-(4-nitro-1-oxoisoindolin-2-yl)piperidine-2,6-dione

(RS)-3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)piperidine-2,6-dione hydrochloride
1243329-97-6

(RS)-3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)piperidine-2,6-dione hydrochloride

Conditions
ConditionsYield
Stage #1: 3-(4-nitro-1-oxoisoindolin-2-yl)piperidine-2,6-dione With hydrogen; palladium 10% on activated carbon In methanol at 21 - 35℃; under 2400.24 Torr; for 18h;
Stage #2: With hydrogenchloride In water
83.5%
methanesulfonic acid
75-75-2

methanesulfonic acid

3-(4-nitro-1-oxoisoindolin-2-yl)piperidine-2,6-dione
827026-45-9

3-(4-nitro-1-oxoisoindolin-2-yl)piperidine-2,6-dione

methanesulfonate salt of 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione

methanesulfonate salt of 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione

Conditions
ConditionsYield
With hydrogen; palladium 10% on activated carbon In methanol under 4654.46 Torr;
With hydrogen; palladium 10% on activated carbon In methanol at 30℃; under 4654.46 Torr; for 3 - 4h;
3-(4-nitro-1-oxoisoindolin-2-yl)piperidine-2,6-dione
827026-45-9

3-(4-nitro-1-oxoisoindolin-2-yl)piperidine-2,6-dione

Reaxys ID: 20308519

Reaxys ID: 20308519

methanesulfonic acid
75-75-2

methanesulfonic acid

3-(4-nitro-1-oxoisoindolin-2-yl)piperidine-2,6-dione
827026-45-9

3-(4-nitro-1-oxoisoindolin-2-yl)piperidine-2,6-dione

3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)piperidine-2,6-dione methylsufonate
1187443-54-4

3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)piperidine-2,6-dione methylsufonate

Conditions
ConditionsYield
With hydrogen; palladium 10% on activated carbon In methanol at 30℃; under 4654.46 Torr;
With palladium 10% on activated carbon; hydrogen In water at 25 - 30℃; under 4654.46 Torr;
3-(4-nitro-1-oxoisoindolin-2-yl)piperidine-2,6-dione
827026-45-9

3-(4-nitro-1-oxoisoindolin-2-yl)piperidine-2,6-dione

(RS)-3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)piperidine-2,6-dione hydrogen sulfate
1243330-05-3

(RS)-3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)piperidine-2,6-dione hydrogen sulfate

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: hydrogen / palladium 10% on activated carbon / methanol / 42 h / 2362.74 Torr
2: sulfuric acid / water / 50 °C
View Scheme
Multi-step reaction with 3 steps
1: hydrogen / palladium 10% on activated carbon / methanol / 18 h / 21 - 35 °C / 2400.24 Torr
2: sodium hydrogencarbonate / water / 65 - 70 °C / pH 8
3: sulfuric acid / water / 50 °C
View Scheme
3-(4-nitro-1-oxoisoindolin-2-yl)piperidine-2,6-dione
827026-45-9

3-(4-nitro-1-oxoisoindolin-2-yl)piperidine-2,6-dione

(RS)-3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)piperidine-2,6-dione sulfate

(RS)-3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)piperidine-2,6-dione sulfate

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: hydrogen / palladium 10% on activated carbon / methanol / 42 h / 2362.74 Torr
2: sulfuric acid / acetic acid / 0.75 h / 70 °C
View Scheme
Multi-step reaction with 3 steps
1: hydrogen / palladium 10% on activated carbon / methanol / 18 h / 21 - 35 °C / 2400.24 Torr
2: sodium hydrogencarbonate / water / 65 - 70 °C / pH 8
3: sulfuric acid / acetic acid / 0.75 h / 70 °C
View Scheme
3-(4-nitro-1-oxoisoindolin-2-yl)piperidine-2,6-dione
827026-45-9

3-(4-nitro-1-oxoisoindolin-2-yl)piperidine-2,6-dione

(RS)-3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)piperidine-2,6-dione sulfate/hydrogen sulfate

(RS)-3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)piperidine-2,6-dione sulfate/hydrogen sulfate

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: hydrogen / palladium 10% on activated carbon / methanol / 42 h / 2362.74 Torr
2: sulfuric acid / water / 50 °C
View Scheme
Multi-step reaction with 3 steps
1: hydrogen / palladium 10% on activated carbon / methanol / 18 h / 21 - 35 °C / 2400.24 Torr
2: sodium hydrogencarbonate / water / 65 - 70 °C / pH 8
3: sulfuric acid / water / 50 °C
View Scheme
3-(4-nitro-1-oxoisoindolin-2-yl)piperidine-2,6-dione
827026-45-9

3-(4-nitro-1-oxoisoindolin-2-yl)piperidine-2,6-dione

1,6′-dithiolenalidomide
1195729-60-2

1,6′-dithiolenalidomide

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: Lawessons reagent / toluene / 26 h / Inert atmosphere; Reflux
2: palladium 10% on activated carbon; hydrogen / methanol / 69 h / 20 °C
View Scheme

827026-45-9Relevant articles and documents

Influence of Linker Attachment Points on the Stability and Neosubstrate Degradation of Cereblon Ligands

Bricelj, Ale?a,Dora Ng, Yuen Lam,Ferber, Dominic,Gütschow, Michael,Kr?nke, Jan,Kuchta, Robert,Müller, Sina,Monschke, Marius,Sosi?, Izidor,Steinebach, Christian,Wagner, Karl G.

, p. 1733 - 1738 (2021/11/16)

Proteolysis targeting chimeras (PROTACs) hijacking the cereblon (CRBN) E3 ubiquitin ligase have emerged as a novel paradigm in drug development. Herein we found that linker attachment points of CRBN ligands highly affect their aqueous stability and neosubstrate degradation features. This work provides a blueprint for the assembly of future heterodimeric CRBN-based degraders with tailored properties.

One-pot method to construct isoindolinones and its application to the synthesis of DWP205109 and intermediate of Lenalidomide

Liu, Jinbiao,Lu, Bowei,Lu, Junrui,Wang, Hongbo,Xie, Zhiqiang,Zhong, Kaikai

, (2021/06/07)

Herein a practical and efficient system for concise synthesis of isoindolinones is described by using substituted methyl 2-(halomethyl)benzoates and substituted amines. Structurally various methyl 2-(halomethyl)benzoates and amines were transformed into isoindolinones 80–99% yield and purity in catalyst-free and solvent-free conditions. The method has a wide substrate scope. The synthetic utility of the one-pot reaction was demonstrated by the concise syntheses of Lenalidomide intermediate and DWP205190.

Method for synthesizing lenalidomide

-

, (2020/01/12)

The invention belongs to the field of chemical synthesis, and particularly relates to a method for synthesizing lenalidomide. The method adopts three-step polymerization, and specifically comprises: (1) carrying out a bromination reaction on 2-methyl-3-nitromethyl benzoate as a starting raw material and a bromination reagent to generate a compound 1 2-bromomethyl-3-nitromethyl benzoate; (2) performing cyclization on the compound 1 and 3-aminopiperidine-2,6-dione hydrochloride under a solvent-free condition to generate a compound 2 3-(4-nitro-1-oxo-1,3-dihydroisoindole-2-yl)piperidine-2,6-dione; and (3) reducing the compound 2 with a reducing agent to obtain lenalidomide. According to the invention, the method is a novel preparation process method of lenalidomide, and has advantages of easily available process raw materials, short steps, simple and convenient operation, environmental friendliness, implementation value of industrial production, and social and economic benefits.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 827026-45-9